(9284) Stellarex
Payments companies reported to CMS as associated with (9284) Stellarex. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with (9284) Stellarex, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with (9284) Stellarex
These are the largest totals companies reported as associated with (9284) Stellarex. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Dion Franga | Orangeburg, SC | Surgery | $134.31 |
| Andras Bikk | Fresno, CA | Vascular Surgery | $95.65 |
| Vamsi Krishna | Kyle, TX | Interventional Cardiology | $92.00 |
| Deepak Nair | University Park, FL | Vascular Surgery | $67.21 |
| Michael Lepore | Sarasota, FL | Vascular Surgery | $67.21 |
| Jason Wagner | Sarasota, FL | Vascular Surgery | $67.21 |
| Douglas Dorsay | Sarasota, FL | Vascular Surgery | $67.20 |
| Sesank Mikkilineni | Lawrenceville, GA | Vascular Surgery | $51.84 |
| David Conn | Lawrenceville, GA | Surgical | $51.83 |
| Daniel Badia | Lawrenceville, GA | Vascular Surgery | $51.83 |
Prescribed (9284) Stellarex?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.